Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002800587 | SCV003033523 | likely benign | Pyogenic arthritis-pyoderma gangrenosum-acne syndrome | 2023-12-11 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003167775 | SCV003880305 | uncertain significance | Inborn genetic diseases | 2023-02-27 | criteria provided, single submitter | clinical testing | The c.1037C>A (p.T346K) alteration is located in exon 14 (coding exon 14) of the PSTPIP1 gene. This alteration results from a C to A substitution at nucleotide position 1037, causing the threonine (T) at amino acid position 346 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |